The European CUP trial: a randomised trial in adults with poor risk relapsed follicular non-hodgkin's lymphoma

Baxter AG (Switzerland)0 个研究点目标入组 0 人开始时间: 2002年8月19日最近更新: 2015年1月13日

适应症

试验速览

暂无简介。

•1. Relapsed follicular non-Hodgkin's lymphoma, after a first or subsequent remission, requiring therapy because of at least one of the following:
•1.1. B symptoms
•1.2. Rapidly progressive disease
•1.3. Bone marrow failure
•1.4. Life threatening organ failure
•2. Aged 15 - 65 years
•3. No central nervous system (CNS) involvement
•4. No previous radiotherapy greater than 2000 cGy to the mediastinum or abdomen, precluding total body irradiation
•5. No previous myeloablative therapy
•6. No prior malignancies, except non-melanomatous skin cancer or cervical carcinoma stage I
•7. Adequate cardiac, neurologic, liver and renal function
•8. No evidence of histlogically proven transformation

发起方

Baxter AG (Switzerland)